The Wire

Nanobiotix Starts New NBTXR3 Study In Lung Cancer Patients

Jul 1, 2021 6:39 AM

Nanobiotix (NASDAQ:NBTX) initiated a new Phase 1 study evaluating NBTXR3 activated by radiation therapy (RT) for...

Like our work? Support the cause.

$5 $10 $20 Custom

Amount $

Card number*

Expiration* /

Name on card*

Security code*